본문 바로가기
KERD
논문KCI 등재

유리체절제술 중 0.025% Brilliant Blue G를 이용한 내경계막 제거

Internal Limiting Membrane Peeling Using 0.025% Brilliant Blue G During Vitrectomy

2

조회

0

다운로드

0

인용

0

참고문헌

키워드

주제분류안과학

초록

목적: 유리체수술에서 내경계막 염색에 사용되는 0.025% Brilliant Blue G (BBG)에 대하여 알아보고자 한다. 대상과 방법: 2011년 1월부터 2013년 8월 사이 유리체절제술과 함께 0.025% BBG 용액을 사용하여 내경계막 제거술을 시행한 환자중 6개월 이상 경과관찰이 가능했던 111명의 의무기록을 후향적으로 분석하였다. 염색을 위한 용액은 BBG를 평형염액에 용해하여0.025%로 희석한 다음 0.22 μm 필터를 통과시켜 소독하여 준비하였다. 유리체절제술 중 유리체를 제거한 다음 황반부위 가까이 유리체강에 주사하여 내경계막을 염색하고 여분의 염색약은 즉시 흡입하여 제거하였다. 결과: 모든 증례에서 내경계막이 성공적으로 제거되어 다른 약제의 추가 사용이 필요하지 않았다. 평균 시력은 술 전 0.80 ± 0.44 (logMAR)에서 술 후 6개월째 0.40 ± 0.39 (p<0.001)로 유의하게 호전되었다. 술 후 합병증으로 안내염과 시신경병증이 각각 1예가발생하였으나 같은 날 동일한 BBG 용액을 사용한 다른 환자에서는 합병증의 발생이 없어 BBG 용액의 사용과 연관성을 확인할 수없었다. 원발성 망막앞막 수술 6개월 후 술 전보다 두 줄 시력이 감소한 환자 1명이 관찰되었다. 그 외 BBG 용액의 사용과 관련이의심되는 합병증은 경과 관찰기간 동안 발견되지 않았다. 결론: 0.025% BBG 용액은 유리체절제술 중 내경계막을 염색하는 데 효과적이었으며 BBG 용액의 사용과 상관성이 확인된 합병증은 관찰되지 않았다.

Abstract

Purpose: To evaluate 0.025% brilliant blue G (BBG) for staining the internal limiting membrane (ILM) during vitrectomy. Methods: In a retrospective, non-comparative clinical case series, we analyzed consecutive 111 patients who underwent pars plana vitrectomy and removal of the ILM after staining using BBG solution. BBG was dissolved and diluted with balanced salt solution at a concentration of 0.025% and then sterilized by filtering through a 0.22 μm millipore filter. The prepared BBG solution was injected into the vitreous cavity over the macula after removal of the vitreous and excessive solution was removed immediately. Results: The ILM was successfully removed without use of additional adjuvant in all cases. Mean best corrected visual acuity (log MAR) was significantly improved from 0.80 ± 0.44 at baseline to 0.40 ± 0.39 at 6 months postoperatively (p < 0.001). One case each of endophthalmitis and diabetic papillopathy developed. The relationship when using BBG solution was not identified as complications were not observed in the other patients who underwent vitrectomy using the same BBG solution on the same day. One idiopathic epiretinal membrane patient had visual acuity loss more than 2 lines. During the follow-up period, other complications suspected to be associated with the use of BBG solution were not observed. Conclusions: A BBG solution (0.025%) was effective in staining the ILM for removal. Complications associated with the use of BBG solution were not observed.

참고문헌 (38)

  1. Eckardt C., "Removal of the internal limiting membrane in macular holes. Clinical and morphological findings", Ophthalmologe, 94, pp.545~551 (1997)
  2. Brooks Jr HL., "Macular hole surgery with and without internal limiting membrane peeling", Ophthalmology, 107, pp.1939~1948 (2000)
  3. Kifuku K., "Residual internal limiting membrane in epiretinal membrane surgery", Br J Ophthalmol, 93, pp.1016~1019 (2009)
  4. Munuera JM., "Optical coherence tomography in successful surgery of vitreomacular traction syndrome", Arch Ophthalmol, 116, pp.1388~1389 (1998)
  5. Ando F., "Optic nerve atrophy after vitrectomy with indocyanine green-assisted internal limiting membrane peeling in diffuse diabetic macular edema", Graefes Arch Clin Exp Ophthalmol, 242, pp.995~999 (2004)
  6. Taniuchi S., "Vitrectomy with or without internal limiting membrane peeling for each stage of myopic traction maculopathy", Retina, 33, pp.2018~2025 (2013)
  7. Burk SE., "Indocyanine green-assisted peeling of the retinal internal limiting membrane", Ophthalmology, 107, pp.2010~2014 (2000)
  8. Gandorfer A., "Indocyanine green selectively stains the internal limiting membrane", Am J Ophthalmol, 131, pp.387~388 (2001)
  9. Kimura H., "Triamcinolone acetonide-assisted peeling of the internal limiting membrane", Am J Ophthalmol, 137, pp.172~173 (2004)
  10. Yip H., "Retinal ganglion cells toxicity caused by photosensitising effects of intravitreal indocyanine green with illumination in rat eyes", Br J Ophthalmol, 90, pp.99~102 (2006)
  11. Engelbrecht NE., "Retinal pigment epithelial changes after macular hole surgery with indocyanine green-assisted internal limiting membrane peeling", Am J Ophthalmol, 133, pp.89~94 (2002)
  12. Sippy BD., "Indocyanine green effect on cultured human retinal pigment epithelial cells : implication for macular hole surgery", Am J Ophthalmol, 132, pp.433~435 (2001)
  13. Narayanan R., "Toxicity of triamcinolone acetonide on retinal neurosensory and pigment epithelial cells", Invest Ophthalmol Vis Sci, 47, pp.722~728 (2006)
  14. Horio N., "Triamcinolone-assisted internal limiting membrane peeling during idiopathic macular hole surgery", Arch Ophthalmol, 123, pp.96~99 (2005)
  15. Enaida H., "Brilliant blue G selectively stains the internal limiting membrane", brilliant blue G-assisted membrane peeling, 2006, pp.26, 631~636
  16. Henrich PB., "Anatomical and functional outcome in brilliant blue G assisted chromovitrectomy", Acta Ophthalmol, 88, pp.588~593 (2010)
  17. Haritoglou C., "Long-term follow-up after macular hole surgery with internal limiting membrane peeling", Am J Ophthalmol, 134, pp.661~666 (2002)
  18. Haritoglou C., "Macular changes after peeling of the internal limiting membrane in macular hole surgery", Am J Ophthalmol, 132, pp.363~368 (2001)
  19. Horio N., "Effect on visual outcome after macular hole surgery when staining the internal limiting membrane with indocyanine green dye", Arch Ophthalmol, 122, pp.992~996 (2004)
  20. Da Mata AP., "Indocyanine green-assisted peeling of the retinal internal limiting membrane during vitrectomy surgery for macular hole repair", Ophthalmology, 108, pp.1187~1192 (2001)
  21. Kwok AK., "Indocyanine green assisted retinal internal limiting membrane removal in stage 3 or 4 macular hole surgery", Br J Ophthalmol, 87, pp.71~74 (2003)
  22. 송병용, "특발황반원공에 있어 Indocyanine green 염색을 이용한 내경계막제거술", 대한안과학회지, 45(3), pp.15~15 (2004), 대한안과학회
  23. Yuen D., "Comparison of the in vitro safety of intraocular dyes using two retinal cell lines: a focus on brilliant blue G and indocyanine green", Am J Ophthalmol, 147, pp.251~259.e252 (2009)
  24. Hisatomi T., "Staining ability and biocompatibility of brilliant blue G : preclinical study of brilliant blue G as an adjunct for capsular staining", Arch Ophthalmol, 124, pp.514~519 (2006)
  25. Chung CF., "Safety of trypan blue 1% and indocyanine green 0. 5% in assisting visualization of anterior capsule during phacoemulsification in mature cataract", J Cataract Refract Surg, 31, pp.938~942 (2005)
  26. Gandorfer A., "Retinal damage from indocyanine green in experimental macular surgery", Invest Ophthalmol Vis Sci, 44, pp.316~323 (2003)
  27. Lee JE., "Toxicity of indocyanine green injected into the subretinal space : subretinal toxicity of indocyanine green", Retina, 23, pp.675~681 (2003)
  28. Rodrigues EB., "Meta-analysis of chromovitrectomy with indocyanine green in macular hole surgery", Ophthalmologica, 222, pp.123~129 (2008)
  29. Jonas J., "Intraocular pressure after intravitreal injection of triamcinolone acetonide", Br J Ophthalmol, 87, pp.24~27 (2003)
  30. Nomoto H., "Macular hole surgery with triamcinolone acetonide-assisted internal limiting membrane peeling : one-year results", Retina, 28, pp.427~432 (2008)
  31. 박운철, "특발성 황반원공의 내경계막 제거 시 트리암시놀론 아세토나이드와 인도사이아닌그린의 비교", 대한안과학회지, 46(12), pp.1995~2003 (2005), 대한안과학회
  32. Pierce J., "An evaluation of the Coomassie brilliant blue G-250 dye-binding method for quantitative protein determination", Anal Biochem, 81, pp.478~480 (1977)
  33. Enaida H., "Preclinical investigation of internal limiting membrane staining and peeling using intravitreal brilliant blue G", Retina, 26, pp.623~630 (2006)
  34. Ejstrup R., "Toxicity profiles of subretinal indocyanine green, Brilliant Blue G, and triamcinolone acetonide : a comparative study", Graefes Arch Clin Exp Ophthalmol, 250, pp.669~677 (2012)
  35. Baba T., "Comparison of vitrectomy with brilliant blue G or indocyanine green on retinal microstructure and function of eyes with macular hole", Ophthalmology, 119, pp.2609~2615 (2012)
  36. Thompson JT., "Epiretinal membrane removal in eyes with good visual acuities", Retina, 25, pp.875~882 (2005)
  37. Pournaras CJ., "Idiopathic macular epiretinal membrane surgery and ILM peeling : anatomical and functional outcomes", Semin Ophthalmol, 26, pp.42~46 (2011)
  38. Haritoglou C., "Heavy brilliant blue G for internal limiting membrane staining", Retina, 31, pp.405~407 (2011)

관련 논문AI추천

이 간행물의 다른 논문 (24건)